CDKN2A and glioblastoma: It is unclear how NF1 could provide a protective prognostic effect in CDKN2Aint patients, but this dichotomous impact of NF1 on survival in CDKN2A stratified patients suggests that CDKN2A may significantly modulate NF1 activity in IDHwt glioblastoma patients.